The Human Milk-derived Peptide Drives Rapid Regulation of Macrophage Inflammation Responses in the Neonatal Intestine
2024

Human Milk Peptide Regulates Inflammation in Newborns

Sample size: 6 publication 10 minutes Evidence: high

Author Information

Author(s): Yuan Fuqiang, Han Xu, Huang Masha, Su Yinglin, Zhang Yiting, Hu Mengyuan, Yu Xiang, Jin Weilai, Li Yun, Zhang Le

Primary Institution: Affiliated Children’s Hospital of Jiangnan University

Hypothesis

The study aimed to explore the role of peptides in human milk extracellular vesicles in regulating macrophage inflammation responses in the neonatal intestine.

Conclusion

The peptide CASB135-150 from human milk rapidly regulates macrophage inflammatory responses and protects against intestinal injury caused by necrotizing enterocolitis.

Supporting Evidence

  • CASB135-150 significantly mitigated intestinal injury in a rat model of necrotizing enterocolitis.
  • Immunofluorescence analysis showed that CASB135-150 targets intestinal macrophages.
  • CASB135-150 disrupted the FHL2/TRAF6 complex, reducing TRAF6 protein levels.

Takeaway

A special protein from human milk helps baby immune cells calm down and prevents gut problems.

Methodology

The study involved screening peptides in human milk EVs, evaluating their effects in a rat model of necrotizing enterocolitis, and analyzing their impact on macrophage inflammation.

Limitations

The study did not fully investigate the impact of endogenous CASB135-150 depletion within EVs on NEC and used intraperitoneal injection, which may not reflect oral administration effects.

Participant Demographics

Neonatal rats were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.jcmgh.2024.101420

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication